Facts & figures
As of: January, 2016
1) primarily from public funds (EU, Federal Government, State Government); according to Campus Buch: total funding since 1992
2) primarily from own ressources, since 2001
3) primarily from own ressources
4) since 2009
5)since 2006
| Research Institutions of Campus Berlin-Buch Employees (total) |
2,091 |
|
| of these: | ||
| Max Delbrück Center for Molecular Medicine (MDC): | 1,624 | |
| Leibniz Institute of Molecular Pharmacology (FMP): | 275 | |
| Klinische Forschung Charité Campus Buch: | 192 | |
| Budget and third-party grants (total)1 | EUR 144 million | |
| Max Delbrück Center for Molecular Medicine (MDC): | EUR 104 million | |
| Leibniz Institute of Molecular Pharmacology (FMP): | EUR 24 million | |
| Klinische Forschung Charité Campus Buch: | EUR 16 million | |
| BiotechPark Berlin-Buch | ||
| Number of companies: | 63 | |
| Employees: | 800 | |
| Annual revenue: Percentage of third-party grants: 3,1% |
EUR 160 million |
|
| Hospitals & Patient-Care Institutions | ||
| Employees (total): of these: |
3,398 | |
| HELIOS Klinikum Berlin-Buch: | 2,550 | |
| Evangelische Lungenklinik: | 314 | |
| Immanuel Krankenhaus Berlin, Standort Buch (Rheumaklinik): | 84 |
|
| Patient-care institutions: | 450 | |
| Number of patient beds: | 1232 | |
| Patients per year (inpatient and outpatient): | 199,400 | |
| Total investment volume of these: |
EUR 1.219 billion | |
| Infrastructure Campus Berlin-Buch1 | EUR 502 million | |
| HELIOS Klinikum Berlin-Buch² | EUR 304 million | |
| Evangelische Lungenklinik3 | EUR 49 million | |
| Immanuel Krankenhaus Berlin, Standort Buch (Rheumaklinik)1 | EUR 38 million |
|
| LudwigPark3 | EUR 45 million | |
| Allées des Châteaux3 | EUR 23 million | |
| Widerker Vermögensverwaltung (Schlosspark-Passage)3 | EUR 28 million |
|
| Housing construction associations (HOWOGE3,4, EWG3,5, Hau+S3,5) | EUR 120 million |
|
| Ludwig Hoffmann Quartier | EUR 110 million |
News Buch Berlin
An in-depth atlas of the heart
Researchers from three continents have produced a first extensive draft of a cell atlas of the human heart to understand how this vital organ functions and to shed light on what goes wrong in cardiova...
more ...DCprime and Glycotope Sign Licensing Agreement to Advance Program Combining Cancer Vaccination and Therapeutic Antibody Platforms
DCprime, the front-runner in the field of relapse vaccines, and Glycotope GmbH, a clinical-stage oncology/immuno-oncology company built on world-leading glycobiology expertise, today announced an expa...
more ...Towards a cell-based interceptive medicine in Europe
Hundreds of researchers, clinicians, industry leaders and policy makers from all around Europe are united by a vision of how to revolutionize healthcare. In a perspective in Nature and the LifeTime St...
more ...Events Buch Berlin
24.10.2020, 09:00
Auf zum „WanderHerbst“ mit der Niederbarnimer Eisenbahn: Romantischer Liepnitzsee
28.10.2020, 09:00
DIGITALE LIFE SCIENCES – Workshops zu den Grundlagen der Bioinformatik und zum Labor 4.0
Neuer Kurs für Technische Angestellten und Laboranten in den Life Sciences: Überblick über aktuelle Themen zur Bioinformatik, Digitalisierung und Automatisierung
more ...
